Tag: EVAQ trial
Mivi Neuroscience presents primary endpoint results from EvaQ trial
Mivi Neuroscience has announced the primary endpoint results of its EvaQ trial—a prospective, multicentre, global, single-arm, US Food and Drug Administration (FDA)-regulated investigational device...
MIVI completes enrolment for study of Q revascularisation system in acute...
MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to assess the safety and effectiveness of the Q revascularisation system...
